Literature DB >> 717519

Massive spontaneous subretinal hemorrhage.

M A Bloome, R S Ruiz.   

Abstract

We studied eight cases of massive, spontaneous subretinal hemorrhage which was characterized by the sudden appearance of one or more large, dark, elevated hematomas under the retina. The initial location of the hemorrhage may have been in the choroid or under the pigment epithelium, or both, but further extravasation of the blood anteriorly frequently resulted in hemorrhage under the neurosensory retina and in the vitreous. Although the lesion can initially be mistaken for a melanoma, the diagnosis is confirmed by the formation of a typical, elevated scar in the involved area. Frequent fundus examinations are essential, and ultrasound, radioactive phosphorus uptake testing, and bilateral patching are helpful in establishing the diagnosis. The hemorrhage is usually the result of a ruptured vessel from a subretinal neovascular network or arterioclerotic degeneration and may be precipitated by the use of anticoagulants.

Entities:  

Mesh:

Year:  1978        PMID: 717519     DOI: 10.1016/0002-9394(78)90181-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  [Massive subretinal hemorrhage and anticoagulants. An unfortunate combination?].

Authors:  C Kuhli-Hattenbach; W Miesbach; I Scharrer; L-O Hattenbach
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

2.  Peripheral exudative hemorrhagic chorioretinopathy in Korean patients.

Authors:  Yun Taek Kim; Se Woong Kang; Jeong-Hee Lee; Song Ee Chung
Journal:  Jpn J Ophthalmol       Date:  2010-06-25       Impact factor: 2.447

3.  Risk of intraocular hemorrhage with new oral anticoagulants.

Authors:  G Talany; M Guo; M Etminan
Journal:  Eye (Lond)       Date:  2016-12-23       Impact factor: 3.775

4.  Massive intraocular hemorrhage associated with anticoagulation and age-related macular degeneration.

Authors:  H Lewis; S H Sloan; R Y Foos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

5.  Peripheral exudative hemorrhagic chorioretinopathy.

Authors:  W H Annesley
Journal:  Trans Am Ophthalmol Soc       Date:  1980

Review 6.  Clinically important ocular reactions to systemic drug therapy.

Authors:  I G Rennie
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

7.  Peripheral Exudative Hemorrhagic Chorioretinopathy with and without treatment-Clinical and multimodal imaging characteristics and prognosis.

Authors:  Margarita Safir; Ofira Zloto; Ido Didi Fabian; Iris Moroz; Dan D Gaton; Vicktoria Vishnevskia-Dai
Journal:  PLoS One       Date:  2022-09-27       Impact factor: 3.752

8.  Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab.

Authors:  Kei Takayama; Tosio Enoki; Teruo Kojima; Sho Ishikawa; Masaru Takeuchi
Journal:  Clin Ophthalmol       Date:  2012-06-07

9.  Updated Systematic Review and Clinical Spectrum of Peripheral Exudative Hemorrhagic Chorioretinopathy.

Authors:  Abdulrahman H Badawi; Valmore A Semidey; Moustafa Magliyah; Hassan Al-Dhibi
Journal:  Middle East Afr J Ophthalmol       Date:  2020-04-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.